Although decreasing the value of k5 (associated with low estrogen level) can reduce the expression of the OCIC marker c-KIT, some clinical evidence suggests that anti-estrogen therapy is only partially effective in the treatment of ovarian cancer [30], [31]. Here, KIT is linked to ovarian carcinoma.